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INTRODUCTION METHODS
RESULTS
CONCLUSIONS
Adoption: 52% of NHS Trusts provide patients with access to a PMHS (67% 
acute; 29% mental health; 18% community; 41% specialist). At 87% of 
Trusts, the helpline was provided by a MI centre. At 4% of Trusts, the 
helpline was provided by the dispensary. 
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No. calls per week was significantly correlated with total no. hours that the helpline was 
available per week, when controlling for no. patients per NHS Trust (r (99) = .31, p < .01).
Implementation: Do NHS Trusts meet recommended national standards 
for operating a PMHS? (n = 108)
Effectiveness: Perceived benefits of PMHS.
Proposed benefits of patient medicines helplines
% who see it as a major benefit
Pharmacists 
(n = 87)
Chief 
Pharmacists  
(n = 66)
Total 
(n = 156)
Avoiding harm to patients (e.g., adverse effects, interactions) 93% 80% 88%
Identifying errors 85% 64% 75%
Learning from patient experiences 55% 56% 55%
Helping the organisation avoid complaints and possible litigation 44% 42% 43%
Improving patient medication adherence 89% 80% 85%
Supporting patient discharge 78% 71% 76%
Providing assurance to patients that they can access 
professional help from home 84% 80% 83%
Improving the patient experience (e.g., patient satisfaction) 84% 76% 80%
Adhering to the NHS constitution (e.g., patients have a right to 
receive information) 40% 30% 37%
Reducing visits to other healthcare services (e.g., GPs, A&E) 52% 53% 51%
Reducing medicines-related readmissions 67% 62% 65%
Improvement in Trust targets and in national surveys 22% 26% 23%
Optimising medicines 76% 73% 75%
Access (‘Satisfactory’ Standards) 
Proportion 
meeting this
Phone line allows direct dialling from outside. 97%
Calls charged at local rate or Freephone. 99%
Contact with a pharmacy professional is always available during advertised hours. 71%
An answerphone allows a message to be left outside of advertised hours. 81%
Total compliance with access ‘satisfactory’ standards. 54%
Availability (‘Satisfactory’ Standards) 
Proportion 
meeting this
Access to patients/carers for a minimum of 4 hours per day. 86%
The helpline is available 5 days per week. 96%
Total compliance with availability ‘satisfactory’ standards. 86%
Promotion (‘Satisfactory’ Standards)
Proportion 
meeting this
Promotional methods agreed with patients locally. 6%
The helpline is promoted at all the healthcare organisation’s sites. 59%
Promotional materials identify access times and types of enquiries people can make. 40%
Total compliance with promotion ‘satisfactory’ standards. 3%
The greatest discrepancy between 
current practice and national 
standards is regarding helpline 
promotion. Simple changes to the 
advertising of PMHS might increase 
their use. It would also be useful to 
ask patients for their reasons for not 
seeking support via the Trust’s PMHS 
(i.e., are they simply not aware that 
the service exists?).
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Response rates: 89% of NHS Trusts completed Survey 1. Additionally, 11% answered 
whether or not they provide patients with access to a PMHS. 54% of Trusts which 
operate a helpline completed Survey 2. 
The first hospital-based patient medicines helpline service (PMHS) 
was established in the UK in 1992 to provide patients with support 
following hospital discharge (1). Since then, PMHS have become 
available at some, but not all, NHS Trusts throughout the UK (2). 
Additionally, studies suggest PMHS may be underused (2). 
Design: Cross-sectional online survey.
Ethics: Approved by the University of Bath Research Ethics Committee.
Participants: Pharmacists and Chief Pharmacists from acute, mental health, 
specialist, and community Trusts were invited to participate.
Materials & Procedure: Two surveys were developed using Surveymonkey. First, 
Survey 1 was sent via email to the pharmacy team at all included NHS Trusts in 
England (227 Trusts). Survey 1 was to be completed by a Pharmacist at the Trust 
(Aim: to answer questions pertaining to the reach, effectiveness, adoption, 
implementation and maintenance of their PMHS, if they provide one). We aimed to 
collect a 100% response rate to establish what proportion of NHS Trusts provide 
patients with access to a patient medicines helpline (RE-AIM Adoption). Non-
responders to Survey 1 were therefore contacted via email or telephone to collect 
this data. Next, Survey 2 was sent to Chief Pharmacists via email at those NHS Trusts 
which operate helplines, as established from Survey 1 (Aim: to also explore Chief 
Pharmacists’ perceptions of PMHS effectiveness). Data were analysed using SPSS. 
64% of acute and specialist NHS Trusts 
provide their patients with access to a 
PMHS, which is the same proportion 
found by the Healthcare Commission 
ten years ago (5). Lack of resources 
was cited as the main reason why 
some NHS Trusts do not currently 
operate a patient medicines helpline.
The perceived benefits suggest that some pharmacists may not be fully aware of 
the evidence as to the impact that PMHS can have. For example, studies suggest 
that patients would seek the advice of their GP had the PMHS not been available 
(6). Yet, only 51% of pharmacists perceive PMHS as being beneficial for reducing 
visits to other healthcare services. A systematic review which brings together 
the available evidence could be advantageous. Additionally, 80% of pharmacists 
perceive that PMHS can improve the patient experience, yet current evidence is 
based upon single-item satisfaction ratings. A qualitative interview study would 
be beneficial to explore in greater depth patients’ experiences of using PMHS. 
Our team is currently in the process of conducting these studies.
Study question: 
“What is the reach, effectiveness, adoption, implementation, and 
maintenance of hospital-based PMHS in England?”
56
Aim/Objective:
The RE-AIM evaluation framework (Reach, Effectiveness, Adoption, 
Implementation, and Maintenance; (3)) was used to obtain key data 
regarding the provision and use of PMHS in NHS Trusts in England. 
This included the extent to which the delivery of helplines meet 
with Royal Pharmaceutical Society endorsed national standards (4).
Reach: Median number of enquiries per week was five (n = 107). PMHS were 
predominantly available for discharged inpatients (98%, n = 110/112), outpatients 
(95%, n = 106/112), and carers (93%, n = 104/112).
Maintenance: Helplines were operated for a median of six years.
